Held on 29 May 2015
Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 29 May 2015, inter alia, has considered and approved the followings:1. Declared Final Dividend at the rate of 50% i.e. Re. 0.50 per share.
2. Sale of Step Down subsidiary Surgimed Pharma located at Kenya;
3. Due to ill health G.G Desai resigned from the Board;
4. Re-appointment of the Statutory Auditor of the Company;
5. Appointment of Secretarial Auditor for the financial year 2015-2016;
6. Appointment of Internal Auditor of the Company for the financial year 2015-16;
7. Adopted the Secretarial Audit report, Board report, Auditors report & Notice of the forthcoming Annual General Meeting;
8. Code of Prevention and Prohibition of Insider Trading in Securities of the Company under SEBl (Prohibition of Insider Trading) Regulation, 2015.
Powered by Capital Market - Live News
